It can assess patientsโ€™ suitability for Amgenโ€™s colorectal cancer drug, Vectibix. Canadian regulatory authorities approved DxSโ€™ TheraScreen K-RAS Mutation Kit for use as a diagnostic for anti-EGFR ...
Company will work with ImClone and BMS to develop FDA-approved test for mCRC patients. DxS is to work with ImClone Systems and Bristol-Myers Squibb on the development of a companion diagnostic for the ...
LOS ANGELES, Oct. 3, 2023 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has granted approval for EntroGen's CRCdx® RAS Mutation Detection Kit as a companion diagnostic for Vectibix® ...
SAN DIEGO, May 19, 2020 /PRNewswire/ -- Invivoscribe to offer the LeukoStrat ® CDx FLT3 Mutation Assay as an FDA approved kit with analysis software. In 2017, Invivoscribe's LeukoStrat ® CDx FLT3 ...
Assures 100x upgraded detection sensitivity compare to ddPCR Higher the possibility of precision medicine in the 1st and 2nd stages of cancer patients SEOUL, South Korea--(BUSINESS WIRE)--GENECAST, ...
The splicing of nuclear pre-mRNA is a fundamental process for the expression of most metazoan genes. More than half of reported exonic mutations in human disease and cancers are due to ...
Testing for genetic mutations has long been complicated, expensive, time-consuming, and, in some parts of the world, inaccessible. Dr. Pierre Billon, an assistant professor at the University of ...
Correlation does not equal causation. Every cancer cell has genetic mutations, but not all of those mutations necessarily ...
Researchers working on an incurable blood cancer can now use a new lab model that could make testing potential new treatments and diagnostics easier and quicker, new research has found. Working with ...
Mutation Detection Kits in Genome Editing Market · GlobeNewswire Inc. Dublin, Oct. 14, 2025 (GLOBE NEWSWIRE) -- The "Mutation Detection Kits in Genome Editing Market Report 2025" has been added to ...
C-kit encodes a receptor tyrosine kinase (RTK) of the same RTK subfamily as the receptors for PDGF, CSF-1 and FLT3 ligand (Rosnet and Birnbaum, 1993). All contain an extracellular ligand-binding ...
The US Food and Drug Administration (FDA) has granted approval for EntroGen's CRCdx RAS Mutation Detection Kit as a companion diagnostic for Vectibix (panitumumab), a targeted therapy used in the ...